文献速递糖尿病

1型糖尿病伴低血糖感知受损者严重低血糖复发的预测因素:HypoCOMPaSS研究

Predictors of Recurrent Severe Hypoglycemia in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia During the HypoCOMPaSS Study.
PubMed 文献 · Diabetes Care · 2019-09-04

HypoCOMPaSS研究纳入96例1型糖尿病伴低血糖感知受损的成人,进行24周2×2析因随机对照试验,比较胰岛素输注与血糖监测方式,以严格避免生化低血糖为目标。分析71例既往12个月有严重低血糖者,随访24个月,43例(61%)完全无严重低血糖复发,28例(39%)仍有复发,复发与干预前严重低血糖率更高、低血糖恐惧及周围神经病变相关。

要点

  • 干预前严重低血糖率更高与24个月严重低血糖复发独立相关。
  • 低血糖恐惧和周围神经病变在复发者中更常见。
  • 复发者低血糖感知受损更重且每日胰岛素总量更低。

核心结论

  • 严重低血糖复发与干预前严重低血糖率更高、低血糖恐惧及合并神经病变相关。

研究设计与样本

  • HypoCOMPaSS为24周2×2析因随机对照试验,纳入96例1型糖尿病伴低血糖感知受损成人,比较胰岛素输注与血糖监测方式,目标为严格避免生化低血糖。
  • 本分析纳入71例干预前12个月有严重低血糖且随访24个月确认无(完全应答)或有(不完全应答)严重低血糖者。

主要发现

  • 43例(61%)为完全应答者,28例(39%)为不完全应答者,后者平均每人年严重低血糖1.5±1.0次。
  • 24个月时不完全应答者血糖≤3 mmol/L时间比例与完全应答者无显著差异(1.4±2.1% vs 3.0±4.8%,P=0.26)。
  • 不完全应答者每日胰岛素总量更低(0.45 vs 0.58 units/24 h,P=0.01),低血糖感知受损更重(Clarke评分3.8±2.2 vs 2.0±1.9,P=0.01)。
  • 不完全应答者基线严重低血糖率更高(16.9±16.3 vs 6.4±10.8 events/person-year,P=0.002),低血糖恐惧更重。
  • 周围神经病变在不完全应答者中更常见(11例[39%] vs 2例[4.7%],P<0.001),自主神经病变有增多趋势。

临床怎么用

  • 对1型糖尿病伴低血糖感知受损者,应评估干预前严重低血糖率、低血糖恐惧及神经病变以识别复发高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The HypoCOMPaSS study was designed to test the hypothesis that successful avoidance of biochemical hypoglycemia without compromising overall glycemic control would restore sufficient hypoglycemia awareness to prevent recurrent severe hypoglycemia in the majority of participants with established type 1 diabetes. Before starting the study, we planned to investigate associations between baseline characteristics and recurrent severe hypoglycemia over 2 years' follow-up. RESEARCH DESIGN AND METHODS: A total of 96 adults with type 1 diabetes and impaired awareness of hypoglycemia participated in a 24-week 2 × 2 factorial randomized controlled trial comparing insulin delivery and glucose monitoring modalities, with the goal of rigorous biochemical hypoglycemia avoidance. The analysis included 71 participants who had experienced severe hypoglycemia in the 12-month prestudy with confirmed absence (complete responder) or presence (incomplete responder) of severe hypoglycemia over 24 months' follow-up. RESULTS: There were 43 (61%) complete responders and 28 (39%) incomplete responders experiencing mean ± SD 1.5 ± 1.0 severe hypoglycemia events/person-year. At 24 months, incomplete responders spent no more time with glucose ≤3 mmol/L (1.4 ± 2.1% vs. 3.0 ± 4.8% for complete responders; P = 0.26), with lower total daily insulin dose (0.45 vs. 0.58 units/24 h; P = 0.01) and greater impairment of hypoglycemia awareness (Clarke score: 3.8 ± 2.2 vs. 2.0 ± 1.9; P = 0.01). Baseline severe hypoglycemia rate (16.9 ± 16.3 vs. 6.4 ± 10.8 events/person-year; P = 0.002) and fear of hypoglycemia were higher in incomplete responders. Peripheral neuropathy was more prevalent in incomplete responders (11 [39%] vs. 2 [4.7%]; P < 0.001) with a trend toward increased autonomic neuropathy. CONCLUSIONS: Recurrent severe hypoglycemia was associated with higher preintervention severe hypoglycemia rate, fear of hypoglycemia, and concomitant neuropathy.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Flatt AJS, Little SA, Speight J, et al. Predictors of Recurrent Severe Hypoglycemia in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia During the HypoCOMPaSS Study. Diabetes Care. 2019. PMID: 31484666. doi:10.2337/dc19-0630

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。